<DOC>
	<DOCNO>NCT00698594</DOCNO>
	<brief_summary>The purpose trial compare efficacy safety sublingual seasonal annual immunotherapy child allergic rhinitis allergic grass pollen .</brief_summary>
	<brief_title>Comparison Effectiveness Safety Sublingual Immunotherapy Children With Allergic Rhinitis</brief_title>
	<detailed_description>Allergen immunotherapy currently one method cause treatment IgE-dependent allergic disease . Sublingual immunotherapy ( SLIT ) method allow give allergen via alternative oral route patient home . Due possibility avoid injection therapy allow good relationship patient , reduce cost therapy thanks reduce number visit out-patient clinic.However efficacy safety sublingual immunotherapy still important issue , especially child . The purpose trial compare efficacy safety sublingual seasonal annual immunotherapy child allergic rhinitis allergic grass pollen .</detailed_description>
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<criteria>Children seasonal allergic rhinitis , allergic grass pollen , first diagnose least 2 year inclusion study Active upper respiratory tract infection within 3 week study acute sinus disease require antibiotic treatment within 1 month study Allergic rhinitis hospitalisation 3 month first visit . Additional criterion clinically significant pulmonary , hematologic , hepatic , gastrointestinal , renal , endocrine , neurologic , cardiovascular , and/or psychiatric disease malignancy either put patient risk participate study could influence result study patient 's ability participate study judge investigator . Excluded medication systemic corticosteroid . Patients receive immunotherapy also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>August 2011</verification_date>
</DOC>